STOCK TITAN
  1. Home
  2. PKBO

PEAK BIO (PKBO) Stock Price, News & Analysis

PKBO OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
45 213 sessions, November 14, 2023 to November 14, 2024
Largest daily move
+976.9% close of September 5, 2024
1-year change
-62.5% closing prices, November 14, 2023 to November 14, 2024
1-month change
-2.2% closing prices, October 14, 2024 to November 14, 2024

Company Description

PKBO has declined 62.5% over the past year. The last closing price was $0.0225.

This page collects what Stock Titan holds for PKBO, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-62.5%
Performance 1 year
-
Market Cap
-
Shares outstanding

PEAK BIO (PKBO) closed at $0.0225 on November 14, 2024. Over the past 12 months, the price has lost 62.5%.

See what a $1,000 investment in PKBO would be worth today

Average down calculator for PKBO

PKBO Metrics & Rankings

Month to date
-67.9%
View ranking
YTD
-88.0%
View ranking

Price returns through November 14, 2024. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

View All
0.00%

Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

acquisition
0.00%

Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit

acquisition
+5.21%

Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing

-13.64%

Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing

-2.50%

Peak Bio, Inc. Announces Up-listing to OTCQB Market

-2.50%

Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors

management
-26.30%

Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market

+2.67%

Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital

-27.98%

Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting

clinical trial
+105.79%

Peak Bio, Inc. Announces Closing of up to $100 Million Common Stock Purchase Transaction with White Lion Capital

PEAK BIO has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, management, clinical trial. View all PKBO news →

SEC Filings

View All

No SEC filings available for PKBO.

Frequently Asked Questions

What is the current quoted price of PEAK BIO (PKBO)?

The current quoted price of PEAK BIO (PKBO) is $0.0225 as of November 14, 2024.